Literature DB >> 6647203

Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.

J J Walker, I Greer, A A Calder.   

Abstract

Patients with acute pregnancy-related hypertension were randomized to treatment with 200 mg oral labetalol or 10 mg intramuscular hydralazine. Labetalol was found to be at least as effective, more predictable, more acceptable and produced no change in heart rate compared to hydralazine.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6647203

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

Review 1.  Preeclampsia. Still an enigma.

Authors:  J Duda
Journal:  West J Med       Date:  1996-04

Review 2.  Effects of antihypertensive drugs on the unborn child: what is known, and how should this influence prescribing?

Authors:  S M Khedun; B Maharaj; J Moodley
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

Review 3.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546

4.  Betaxolol: a pilot study of its pharmacological and therapeutic properties in pregnancy.

Authors:  M J Boutroy; P L Morselli; G Bianchetti; J L Boutroy; L Pépin; A Zipfel
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 5.  Drugs for treatment of very high blood pressure during pregnancy.

Authors:  Lelia Duley; Shireen Meher; Leanne Jones
Journal:  Cochrane Database Syst Rev       Date:  2013-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.